Grants for Independent school districts - Health

The "Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research" grant aims to encourage existing NCI P30 centers to enhance their current research by integrating new technologies from the NCI Innovative Molecular Analysis Technologies program, with the goal of advancing cancer research and promoting scientific discovery.

This grant provides funding to state and local governments, nonprofits, and educational institutions to help enroll eligible children in Medicaid and CHIP while improving their retention in these programs.

This funding opportunity provides financial support for organizations to host conferences and workshops that promote research integrity and ethical practices in research across various disciplines.

The purpose of the Cancer Immunoprevention Network (CIP-Net) is to support a deeper understanding of basic mechanisms of immunoprevention, discover novel immunoprevention strategies, and foster a community of cancer immunoprevention researchers. ?The UG3/UH3 research projects will enable de novo discovery of immune pathways, immunoprevention mechanisms, or investigation of new vaccine or immunomodulatory targets or agents. Applicants responding to this FOA must apply for both the UG3 and UH3 phases together in a single application. Achievement of the UG3 milestones will be necessary for transition to the UH3 phase. UH3 phase may be awarded after administrative review of the UG3 milestones. Provided these milestones are achieved, UH3 phase may continue.

This grant provides funding to organizations that evaluate and improve healthcare delivery by using patient-centered research to reduce disparities in care, particularly for underserved populations.

The Platteville Community Fund, established in 2002 by the Community Foundation of Southern Wisconsin, is a permanent, unrestricted charitable endowment dedicated to enhancing various aspects of community life in the Platteville area. Its mission aligns with supporting projects that enrich the arts, education, health and human services, the environment, and historic preservation. This broad focus allows the fund to address a diverse range of community needs and contribute to the overall well-being and cultural vibrancy of Platteville. Annually, a portion of the Fund's earnings is distributed back to the community in the form of grants. These grants target non-profit organizations, the local school district, and/or local government agencies that provide charitable programs or projects serving the community. The impact goals are centered on fostering community development and addressing specific concerns within Platteville, as evidenced by entities like the PHS Scholarship Fund, created in 2010, and the Platteville Excellence in Education Endowment Fund. The fund's strategic priorities include empowering local citizens to support charitable interests through various focused funds, as well as providing essential funding for the Platteville School District's educational needs not covered by the regular budget, exemplified by the EIE fund's inception in 2021. The theory of change suggests that by providing accessible grant funding and facilitating community-driven initiatives, the fund can significantly strengthen the social, cultural, and educational infrastructure of Platteville. The expected outcomes of these grants include improved access to arts and cultural programs, enhanced educational opportunities, better health and human services, a healthier environment, and preserved historical assets. While specific measurable results for all grant categories are not explicitly detailed in the provided information, the existence of funds like the EIE fund with an initial grant of over $30,000 indicates a commitment to substantial financial support and measurable educational impact within the school district. The advisory board, composed of volunteer citizens, plays a crucial role in initiating fundraising and determining grant awards, ensuring that resources are allocated effectively to achieve these community-focused goals.

This funding opportunity provides financial support to Ohio educational institutions for enhancing school safety and improving school climate through training and equipment, with a focus on collaboration with local law enforcement.

State Promotion of Strategies to Advance Oral Health is a three-year competitive announcement that continues the Centers for Disease Control and Prevention's investment in supporting oral health programs. This Funding Opportunity Announcement aims to enable recipients to focus on priority populations and the following strategies: 1) access to optimally fluoridated water and receipt of Evidence-based Preventive Dental Services, 2) adherence to infection prevention and control recommendations, 3) access to data to build evidence for public health practice, and 4) access to care and untreated decay, and 5) foundational information supporting integrated medical and dental services for persons with diabetes. The proposed program follows previous Notice of Funding Opportunities (NOFOs) and incorporates programmatic strategies implemented in NOFO DP18-1810 [FY2018 FY2023].

This funding opportunity supports innovative research projects aimed at developing new treatments and improving recovery processes for individuals with alcohol use disorder, particularly in underserved populations.

This funding opportunity supports research projects that develop and evaluate behavioral interventions to encourage and sustain interest in biomedical research careers, particularly focusing on diversity and mentorship.

This funding opportunity provides financial support to local organizations in Zimbabwe to implement comprehensive HIV prevention and treatment programs, focusing on key populations and improving health services to achieve and maintain epidemic control.

This funding opportunity provides financial support to a wide range of organizations to strengthen Uganda's health security by improving disease detection, response systems, and surveillance capabilities.

This funding opportunity supports U.S.-based institutions and organizations in developing innovative human-based research models to improve understanding of health and disease, with a focus on inclusivity and collaboration.

This funding opportunity supports innovative research projects that explore how brain circuits develop and influence behavior in rodents and non-human primates, with a focus on mental health across different developmental stages.

This funding opportunity supports research on the effects of HIV/AIDS on communication disorders, aiming to improve the quality of life for people living with HIV through innovative studies and collaborations.

This funding opportunity supports the establishment of research centers that create advanced animal models for studying diseases, enabling better translation of genetic research into human health applications, and is open to a variety of eligible institutions and organizations.

This funding opportunity supports innovative research projects focused on developing and testing radionuclide-based cancer therapies, particularly in preclinical settings, to improve treatment outcomes and understanding of their effects on tumors and normal tissues.

This funding opportunity supports innovative research projects that leverage biomedical informatics and data science to improve health outcomes, targeting a wide range of eligible applicants including universities, nonprofits, and small businesses.

The purpose of the NIH Midcareer Investigator Award in Patient-Oriented Research (K24) is to provide support to mid-career health-professional doctorates for protected time to devote to patient-oriented research (POR) and to act as research mentors primarily for clinical residents, clinical fellows and/or junior clinical faculty. Section IV. Application and Submission Information 1. Requesting an Application Package The application forms package specific to this opportunity must be accessed through ASSIST, Grants.gov Workspace or an institutional system-to-system solution. Links to apply using ASSIST or Grants.gov Workspace are available in Part 1 of this FOA. See your administrative office for instructions if you plan to use an institutional system-to-system solution. 2. Content and Form of Application Submission It is critical that applicants follow the Career Development (K) Instructions in the SF424 (R&R) Application Guide, except where instructed in this funding opportunity announcement to do otherwise. Conformance to the requirements in the Application Guide is required and strictly enforced. Applications that are out of compliance with these instructions may be delayed or not accepted for review. Page Limitations All page limitations described in the SF424 (R&R) Application Guide and the Table of Page Limits must be followed. Instructions for Application Submission Note: Effective for due dates on or after January 25, 2023, the Data Management and Sharing (DMS) Plan will be attached in the Other Plan(s) attachment in FORMS-H and subsequent application forms packages. For due dates on or before January 24, 2023, the Data Sharing Plan and Genomic Data Sharing Plan GDS) will continue to be attached in the Resource Sharing Plan attachment in FORMS-G application forms packages. The following section supplements the instructions found in the SF 424 (R&R) Application Guide and should be used for preparing an application to this FOA. SF424(R&R) Cover All instructions in the SF424 (R&R) Application Guide must be followed. SF424(R&R) Project/Performance Site Locations All instructions in the SF424 (R&R) Application Guide must be followed. Other Project Information All instructions in the SF424 (R&R) Application Guide must be followed SF424(R&R) Senior/Key Person Profile Expanded All instructions in the SF424 (R&R) Application Guide must be followed. IMPORTANT REMINDER: The personal profile associated with the eRA Commons username entered in the Credential field for the PD/PI (candidate) must include an ORCID ID. For more information on linking an ORCID ID to an eRA Commons personal profile see the ORCID topic in our eRA Commons online help. R&R Budget All instructions in the SF424 (R&R) Application Guide must be followed. PHS 398 Cover Page Supplement All instructions in the SF424 (R&R) Application Guide must be followed. PHS 398 Career Development Award Supplemental Form Other Plan(s): Note: Effective for due dates on or after January 25, 2023, the Data Management and Sharing Plan will be attached in the Other Plan(s) attachment in FORMS-H and subsequent application forms packages. For due dates on or before January 24, 2023, the Data Sharing Plan and Genomic Data Sharing Plan GDS) will continue to be attached in the Resource Sharing Plan attachment in FORMS-G application forms packages. All applicants planning research (funded or conducted in whole or in part by NIH) that results in the generation of scientific data are required to comply with the instructions for the Data Management and Sharing Plan. All applications, regardless of the amount of direct costs requested for any one year, must address a Data Management and Sharing Plan. The PHS 398 Career Development Award Supplemental Form is comprised of the following sections: Candidate Research Plan Other Candidate Information Mentor, Co-Mentor, Consultant, Collaborators Environment & Institutional Commitment to the Candidate Other Research Plan Sections Appendix All instructions in the SF424 (R&R) Application Guide must be followed, with the following additional instructions: Candidate Section All instructions in the SF424 (R&R) Application Guide must be followed, with the following additional instructions: Candidate Information and Goals for Career Development Candidate’s Background Provide details of the candidate’s immediate and long-term career objectives in POR and in mentoring new clinician investigators. Include a summary of the research career of the candidate, documenting the ability of the candidate to conduct high quality POR and commitment to a career in POR. Document the ability of the K24 candidate to provide mentoring to new clinician investigators without duplicating information in the biosketch. Provide the number of years of mentoring experience, mentoring role (i.e., research advisor, clinical mentor, etc.), the number of clinicians mentored, the specialties of the individual mentees and the stages in their professional career. In addition, describe the types of research that were conducted by the individuals mentored, and the proportion of mentored individuals currently in academic medicine and/or directly participating in POR. Provide an explanation as to how relief from patient care or administrative responsibilities through the protected time provided by this award will contribute to the development or expansion of the candidate’s POR program and increased level of commitment to mentoring new and early stage clinician investigators. It is important to convey to the reviewers the reasons for needing protected time to continue a vital research program and continue to engage in the mentoring of new scientists. It should be clear that this award will permit the candidate to spend more time on research and mentoring and less time on administrative and clinical responsibilities for the institution. Career Goals and Objectives Describe the candidate's career goals and objectives under this award, including prior experience, and current research support. Candidates are encouraged to provide a timeline for accomplishing these goals and how this award will enhance mentoring or inclusion of mentoring in their career activities. Candidate’s Plan for Career Development/Training Activities During Award Period Describe the professional responsibilities/activities including other research projects beyond the minimum required effort commitment to the career award. Explain how these responsibilities/activities will help ensure career progression to achieve independence as an investigator. The candidate should describe any new or enhanced research skills and knowledge he/she will acquire during the career award period, and how these skills and experiences will significantly enhance his/her ability to continue his/her research programs as an independent scientist. Research Plan Section All instructions in the SF424 (R&R) Application Guide must be followed, with the following additional instructions: Research Strategy Currently supported research: There is no need to provide extensive detail with regard to ongoing, funded research. Enough information should, however, be provided in the areas of Hypotheses and Specific Aims; Background, Significance and Rationale; Preliminary Studies and Results; and Research Design and Methods to permit the peer reviewers to evaluate the extent, special features and general quality of the candidate's research activities and opportunities for mentoring. New research to be specifically supported by this award: Describe how this award will be used to help augment the candidate’s research skills and/or develop new directions in POR. This description should include a Statement of Hypothesis and Specific Aims; Background, Preliminary Studies and Aims; Significance and Rationale; and Research Design and Methods. Although it is not expected that this description would be as detailed as an application for an investigator-initiated research grant (e.g., R01), it is expected that sufficient detail be provided to permit an evaluation of the scientific merit of the research, and to clearly show research opportunities for mentoring. Documentation must be provided that appropriate and adequate resources, both in terms of support and facilities are available to the candidate to conduct the research program(s). This is an important part of the application because it will provide the main rationale and justification for needing protected time for research. The candidate must ensure that the inclusion of women, members of minority groups and their subpopulations, and children, has been addressed in the development of the design for all proposed patient-oriented research. The candidate must provide this information for each new research project proposed. Candidates must provide plans for ensuring continuing support of their POR programs preferably with them as the PD/PI. If the applicant is proposing to gain experience in a clinical trial, ancillary clinical trial or a clinical trial feasibility study as part of his or her research career development, describe the relationship of the proposed research project to the clinical trial. Training in the Responsible Conduct of Research All applications must include a plan to fulfill NIH requirements for instruction in the Responsible Conduct of Research (RCR). See SF424 (R&R) Application Guide for instructions. Other Candidate Information Section Candidate's Plan to Provide Mentoring This required component should include a description of the availability of appropriate junior investigators for mentoring; their previous training and specialization; plans for recruitment, selection and supervision; the types of educational and research experiences that will be provided; and the capacity in which the candidate for the career award will serve as a mentor. If there is an existing (clinical) research curriculum (e.g., through a CTSA), describe how the mentoring plan will be integrated with the curriculum. Candidates must also describe a plan for supporting the research of their mentees during the period of the career award. Candidates must indicate the proposed person months committed to the mentoring plan. Mentor, Co-Mentor, Consultant, Collaborators Section All instructions in the SF424 (R&R) Application Guide must be followed, with the following additional instructions: Plans and Statements of Mentor and Co-mentor(s) Not Applicable Letters of Support from Collaborators, Contributors and Consultants Signed statements must be provided by all collaborators and/or consultants confirming their participation in the project and describing their specific roles. Collaborators and consultants do not need to provide their biographical sketches unless also listed as senior/key personnel. However, information should be provided clearly documenting the appropriate expertise in the proposed areas of consulting/collaboration. Environmental and Institutional Commitment to the Candidate All instructions in the SF424 (R&R) Application Guide must be followed, with the following additional instructions: Description of Institutional Environment The sponsoring institution must document a strong, well-established research and career development program related to the candidate's area of interest, including a high-quality research environment with key faculty members and other investigators capable of productive collaboration with the candidate. Describe how the institutional research environment is particularly suited for the development of the candidate's research career and the pursuit of the proposed research plan. Describe the resources and facilities that will be available to the candidate Institutional Commitment to the Candidate’s Research Career Development The sponsoring institution must provide a statement of commitment to the candidate's development into a productive, independent investigator and to meeting the requirements of this award. It should be clear that the institutional commitment to the candidate is not contingent upon receipt of this career award. The letter of commitment from the institution should provide statements concerning the amount of protected time the candidate will receive (3-6 person-months or 25 to 50% full-time professional effort required); the duties from which he/she will be relieved (if clinical duties, the institution should describe specific steps that will be taken to cover these duties, such as hiring clinical staff); and the institutional commitment to enhancing the candidate's ability to be a productive, independent investigator. Appendix Limited items are allowed in the Appendix. Follow all instructions for the Appendix as described in the SF424 (R&R) Application Guide; any instructions provided here are in addition to the SF424 (R&R) Application Guide instructions. PHS Human Subjects and Clinical Trials Information When involving human subjects research, clinical research, and/or NIH-defined clinical trials (and when applicable, clinical trials research experience) follow all instructions for the PHS Human Subjects and Clinical Trials Information form in the SF424 (R&R) Application Guide, with the following additional instructions: If you answered “Yes” to the question “Are Human Subjects Involved?” on the R&R Other Project Information form, you must include at least one human subjects study record using the Study Record: PHS Human Subjects and Clinical Trials Information form or a Delayed Onset Study record. Study Record: PHS Human Subjects and Clinical Trials Information All instructions in the SF424 (R&R) Application Guide must be followed with the following additional instructions: Do not complete Section 4 – Protocol Synopsis information or Section 5 - Other Clinical Trial-related Attachments. Delayed Onset Study Note: Delayed onset does NOT apply to a study that can be described but will not start immediately (i.e., delayed start). All instructions in the SF424 (R&R) Application Guide must be followed. PHS Assignment Request Form All instructions in the SF424 (R&R) Application Guide must be followed. 3. Unique Entity Identifier and System for Award Management (SAM) See Part 1. Section III.1 for information regarding the requirement for obtaining a unique entity identifier and for completing and maintaining active registrations in System for Award Management (SAM), NATO Commercial and Government Entity (NCAGE) Code (if applicable), eRA Commons, and Grants.gov. 4. Submission Dates and Times Part I. Overview Information contains information about Key Dates and Times. Applicants are encouraged to submit applications before the due date to ensure they have time to make any application corrections that might be necessary for successful submission. When a submission date falls on a weekend or Federal holiday, the application deadline is automatically extended to the next business day. Organizations must submit applications to Grants.gov (the online portal to find and apply for grants across all Federal agencies) using ASSIST or other electronic submission systems. Applicants must then complete the submission process by tracking the status of the application in the eRA Commons, NIH’s electronic system for grants administration. NIH and Grants.gov systems check the application against many of the application instructions upon submission. Errors must be corrected and a changed/corrected application must be submitted to Grants.gov on or before the application due date. and time. If a Changed/Corrected application is submitted after the deadline, the application will be considered late. Applications that miss the due date and time are subjected to the NIH Policy on Late Application Submission. Applicants are responsible for viewing their application before the due date in the eRA Commons to ensure accurate and successful submission. Information on the submission process and a definition of on-time submission are provided in the SF424 (R&R) Application Guide. 5. Intergovernmental Review (E.O. 12372) This initiative is not subject to intergovernmental review. 6. Funding Restrictions All NIH awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement. Pre-award costs are allowable only as described in the NIH Grants Policy Statement. 7. Other Submission Requirements and Information Applications must be submitted electronically following the instructions described in the SF424 (R&R) Application Guide. Paper applications will not be accepted. Applicants must complete all required registrations before the application due date. Section III. Eligibility Information contains information about registration. For assistance with your electronic application or for more information on the electronic submission process, visit How to Apply – Application Guide. If you encounter a system issue beyond your control that threatens your ability to complete the submission process on-time, you must follow the Dealing with System Issues guidance. For assistance with application submission contact the Application Submission Contacts in Section VII. Important reminders: All PD(s)/PI(s) must include their eRA Commons ID in the Credential field of the Senior/Key Person Profile Component of the SF424(R&R) Application Package. Failure to register in the Commons and to include a valid PD/PI Commons ID in the credential field will prevent the successful submission of an electronic application to NIH. The applicant organization must ensure that the DUNS number it provides on the application is the same number used in the organization’s profile in the eRA Commons and for the System for Award Management (SAM). Additional information may be found in the SF424 (R&R) Application Guide. See more tips for avoiding common errors. Upon receipt, applications will be evaluated for completeness and compliance with application instructions by the Center for Scientific Review, NIH. Applications that are incomplete or non-compliant will not be reviewed. Post Submission Materials Applicants are required to follow the instructions for post-submission materials, as described in the policy. Any instructions provided here are in addition to the instructions in the policy. Section V. Application Review Information 1. Criteria Note: Effective for due dates on or after January 25, 2023, the Data Sharing Plan and Genomic Data Sharing Plan (GDS) as part of the Resource Sharing Plan will not be evaluated at time of review. Only the review criteria described below will be considered in the review process. Applications submitted to the NIH in support of the NIH mission are evaluated for scientific and technical merit through the NIH peer review system. Overall Impact Reviewers should provide their assessment of the likelihood that the proposed career development and research plan will enhance the candidate’s potential for a productive, independent scientific research career in a health-related field, taking into consideration the criteria below in determining the overall impact score. Scored Review Criteria Reviewers will consider each of the review criteria below in the determination of scientific merit, and give a separate score for each. An application does not need to be strong in all categories to be judged likely to have major scientific impact. Candidate Is there evidence of ongoing high quality patient-oriented research, and what is the relationship of that research to this K24 application? Is there evidence of the candidate's capabilities and commitment to serve as a mentor for new clinical investigators in the conduct of patient-oriented research? Does the application demonstrate that the proposed program and protected time will relieve the candidate from non-research patient care and administrative duties and allow him/her to devote additional time and to augment his/her capabilities in patient-oriented research? Does the application demonstrate a record of independent peer-reviewed support for patient-oriented research that is likely to continue during the K24 award? Plan to Provide Mentoring Are the plans to provide mentoring or supervising new clinical investigators in patient oriented research adequate? Are plans to integrate appropriate clinical research curricula, into the mentoring plans adequate? Is an appropriate level of effort proposed for the mentoring component? Research Plan Candidates are expected to have independent, peer reviewed research support at the time the career award is made. In such instances, reviewers should not re-evaluate the research plan. Rather, the reviewers should evaluate how the research and career development plans together further the candidate’s research career. Is the research plan an appropriate vehicle for demonstrating and developing the prospective mentee’s skills and capabilities in patient-oriented research? Are the scientific and technical plans of the proposed research of merit? Is the proposed research relevant to the candidate's career objectives? Are adequate resources available to conduct the research program? This includes adequacy of plans for continued support of the research during the funding period of the grant. If proposed, will the clinical trial experience contribute to the proposed research project? Consultant(s), Collaborator(s) Is adequate information provided that clearly documents expertise in the proposed area(s) of consulting/collaboration? Environment & Institutional Commitment to the Candidate Are the research facilities, resources and training opportunities, including faculty capable of productive collaboration with the candidate adequate and appropriate? Is there assurance that the institution intends the candidate to be an integral part of its research program as an independent investigator? Is the level of the applicant institution’s commitment to the scientific development of the candidate appropriate? Are the size and quality of the pool of clinician investigators to be mentored by the PD/PI adequate? Are the quality and relevance of the environment for continuing the scientific and professional development of the candidate and for others pursuing patient-oriented research appropriate and adequate? Is there adequate commitment from the sponsoring institution to provide protected time for the candidate to conduct the research and mentoring program? Is the level of commitment of the candidate’s institution to the career development in patient-oriented research of new clinical investigators mentored by the candidate adequate? Additional Review Criteria As applicable for the project proposed, reviewers will evaluate the following additional items while determining scientific and technical merit, and in providing an overall impact score, but will not give separate scores for these items. Protections for Human Subjects For research that involves human subjects but does not involve one of the categories of research that are exempt under 45 CFR Part 46, the committee will evaluate the justification for involvement of human subjects and the proposed protections from research risk relating to their participation according to the following five review criteria: (1) risk to subjects, (2) adequacy of protection against risks, (3) potential benefits to the subjects and others, (4) importance of the knowledge to be gained, and (5) data and safety monitoring for clinical trials. For research that involves human subjects and meets the criteria for one or more of the categories of research that are exempt under 45 CFR Part 46, the committee will evaluate: (1) the justification for the exemption, (2) human subjects involvement and characteristics, and (3) sources of materials. For additional information on review of the Human Subjects section, please refer to the Guidelines for the Review of Human Subjects. Inclusion of Women, Minorities, and Individuals Across the Lifespan When the proposed project involves human subjects and/or NIH-defined clinical research, the committee will evaluate the proposed plans for the inclusion (or exclusion) of individuals on the basis of sex/gender, race, and ethnicity, as well as the inclusion (or exclusion) of individuals across the lifespan (including children and older adults) to determine if it is justified in terms of the scientific goals and research strategy proposed. For additional information on review of the Inclusion section, please refer to the Guidelines for the Review of Inclusion in Clinical Research. Vertebrate Animals The committee will evaluate the involvement of live vertebrate animals as part of the scientific assessment according to the following criteria: (1) description of proposed procedures involving animals, including species, strains, ages, sex, and total number to be used; (2) justifications for the use of animals versus alternative models and for the appropriateness of the species proposed; (3) interventions to minimize discomfort, distress, pain and injury; and (4) justification for euthanasia method if NOT consistent with the AVMA Guidelines for the Euthanasia of Animals. Reviewers will assess the use of chimpanzees as they would any other application proposing the use of vertebrate animals. For additional information on review of the Vertebrate Animals section, please refer to the Worksheet for Review of the Vertebrate Animal Section. Biohazards Reviewers will assess whether materials or procedures proposed are potentially hazardous to research personnel and/or the environment, and if needed, determine whether adequate protection is proposed. Resubmissions For Resubmissions, the committee will evaluate the application as now presented, taking into consideration the responses to comments from the previous scientific review group and changes made to the project. Renewals For Renewals, the committee will consider the progress made in the last funding period. Revisions For Revisions, the committee will consider the appropriateness of the proposed expansion of the scope of the project. If the Revision application relates to a specific line of investigation presented in the original application that was not recommended for approval by the committee, then the committee will consider whether the responses to comments from the previous scientific review group are adequate and whether substantial changes are clearly evident.

This funding opportunity supports the establishment of a Coordinating Center to enhance diversity in the aging research workforce through targeted undergraduate education initiatives.